IOBT Short Long Term Debt from 2010 to 2024
| IOBT Stock | USD 0.75 0.04 5.63% |
Short and Long Term Debt | First Reported 2010-12-31 | Previous Quarter 7.8 M | Current Value 6.9 M | Quarterly Volatility 485.7 K |
Check IO Biotech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among IO Biotech's main balance sheet or income statement drivers, such as Net Interest Income of 5 M, Depreciation And Amortization of 204.2 K or Interest Expense of 2.9 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.65. IOBT financial statements analysis is a perfect complement when working with IO Biotech Valuation or Volatility modules.
IOBT | Short Long Term Debt |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for IOBT Stock Analysis
When running IO Biotech's price analysis, check to measure IO Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IO Biotech is operating at the current time. Most of IO Biotech's value examination focuses on studying past and present price action to predict the probability of IO Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IO Biotech's price. Additionally, you may evaluate how the addition of IO Biotech to your portfolios can decrease your overall portfolio volatility.